| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Endocrine Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts 02114
Address all correspondence and requests for reprints to: F. R. Bringhurst, M.D., Endocrine Unit/Wellman 5, Massachusetts General Hospital, Boston, Massachusetts 02114.
PTH recruits and activates osteoclasts to cause bone resorption. These actions of PTH are thought to be mediated indirectly via type 1 PTH/PTH-related peptide receptors (PTH1Rs) expressed by adjacent marrow stromal or osteoblastic cells, although some evidence suggests that PTH may act directly on early hematopoietic osteoclast progenitors. We have established clonal, conditionally immortalized, PTH-responsive, bone marrow stromal cell lines from mice that harbor both a transgene encoding a temperature-sensitive mutant of the simian virus 40 large T antigen and deletion of a single allele of the PTH1R gene. Of 60 stromal cell lines isolated, 45 expressed functional PTH1Rs. During coculture with normal murine spleen cells, 5 of 42 such cell lines could support formation of tartrate-resistant acid phosphatase-positive, multinucleated cells (TRAP+ MNCs) in response to 1,25-dihydroxyvitamin D3, but only 2 of these did so in response to PTH. One of these, MS1 cells, expressed numerous cytokines and proteins characteristic of the osteogenic lineage and showed increased production of interleukin-6 in response to PTH. MS1 cells supported dose-dependent induction by rat (r) PTH-(134) (0.1100 nM) of TRAP+ MNCs that expressed calcitonin receptors and formed resorption lacunae on dentine slices. This effect of PTH, which required cell to cell contact between MS1 and spleen cells, was mimicked by coadministration of cAMP analog and phorbol ester but only partially by either agent alone. The carboxyl-terminal fragment rPTH-(5384) also induced osteoclast-like cell formation, but the maximal effect was only 30% as great as that of rPTH-(134). Importantly, rPTH-(134) induced TRAP+ MNC formation even when PTH1R-/- osteoclast progenitors (from fetal liver of mice homozygous for ablation of the PTH1R gene) were cocultured with MS1 cells. We conclude that activation of PTH1Rs on cells of the osteoclast lineage is not required for PTH-(134)-induced osteoclast formation in the presence of appropriate PTH-responsive marrow stromal cells. MS1 cells provide a useful model for further study of PTH regulation of osteoclastogenesis.
This article has been cited by other articles:
![]() |
S. Kim, M. Yamazaki, N. K. Shevde, and J. W. Pike Transcriptional Control of Receptor Activator of Nuclear Factor-{kappa}B Ligand by the Protein Kinase A Activator Forskolin and the Transmembrane Glycoprotein 130-Activating Cytokine, Oncostatin M, Is Exerted through Multiple Distal Enhancers Mol. Endocrinol., January 1, 2007; 21(1): 197 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Fu, S. C. Manolagas, and C. A. O'Brien Parathyroid Hormone Controls Receptor Activator of NF-{kappa}B Ligand Gene Expression via a Distant Transcriptional Enhancer. Mol. Cell. Biol., September 1, 2006; 26(17): 6453 - 6468. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, M. Yamazaki, L. A. Zella, N. K. Shevde, and J. W. Pike Activation of Receptor Activator of NF-{kappa}B Ligand Gene Expression by 1,25-Dihydroxyvitamin D3 Is Mediated through Multiple Long-Range Enhancers. Mol. Cell. Biol., September 1, 2006; 26(17): 6469 - 6486. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Murray, L. G. Rao, P. Divieti, and F. R. Bringhurst Parathyroid Hormone Secretion and Action: Evidence for Discrete Receptors for the Carboxyl-Terminal Region and Related Biological Actions of Carboxyl- Terminal Ligands Endocr. Rev., February 1, 2005; 26(1): 78 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hirotani, N. A. Tuohy, J.-T. Woo, P. H. Stern, and N. A. Clipstone The Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway Regulates Osteoclastogenesis in RAW264.7 Cells J. Biol. Chem., April 2, 2004; 279(14): 13984 - 13992. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. H. Lerner NEW MOLECULES IN THE TUMOR NECROSIS FACTOR LIGAND AND RECEPTOR SUPERFAMILIES WITH IMPORTANCE FOR PHYSIOLOGICAL AND PATHOLOGICAL BONE RESORPTION Crit. Rev. Oral. Biol. Med., March 1, 2004; 15(2): 64 - 81. [Abstract] [Full Text] |
||||
![]() |
R. Chiusaroli, A. Maier, M. C. Knight, M. Byrne, L. M. Calvi, R. Baron, S. M. Krane, and E. Schipani Collagenase Cleavage of Type I Collagen Is Essential for Both Basal and Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor-Induced Osteoclast Activation and Has Differential Effects on Discrete Bone Compartments Endocrinology, September 1, 2003; 144(9): 4106 - 4116. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Fu, R. L. Jilka, S. C. Manolagas, and C. A. O'Brien Parathyroid Hormone Stimulates Receptor Activator of NFkappa B Ligand and Inhibits Osteoprotegerin Expression via Protein Kinase A Activation of cAMP-response Element-binding Protein J. Biol. Chem., December 6, 2002; 277(50): 48868 - 48875. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Ragab, J. L. Nalepka, Y. Bi, and E. M. Greenfield Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells Am J Physiol Cell Physiol, September 1, 2002; 283(3): C679 - C687. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-Y. Liu, P.-W. Wu, F. R. Bringhurst, and J.-T. Wang Estrogen Inhibition of PTH-Stimulated Osteoclast Formation and Attachment in Vitro: Involvement of Both PKA and PKC Endocrinology, February 1, 2002; 143(2): 627 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Divieti, M. R. John, H. Juppner, and F. R. Bringhurst Human PTH-(7-84) Inhibits Bone Resorption in Vitro Via Actions Independent of the Type 1 PTH/PTHrP Receptor Endocrinology, January 1, 2002; 143(1): 171 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gori, P. Divieti, and M. B. Demay Cloning and Characterization of a Novel WD-40 Repeat Protein That Dramatically Accelerates Osteoblastic Differentiation J. Biol. Chem., November 30, 2001; 276(49): 46515 - 46522. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Kearns, M. M. Donohue, B. Sanyal, and M. B. Demay Cloning and Characterization of a Novel Protein Kinase That Impairs Osteoblast Differentiation in Vitro J. Biol. Chem., November 2, 2001; 276(45): 42213 - 42218. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Divieti, N. Inomata, K. Chapin, R. Singh, H. Juppner, and F. R. Bringhurst Receptors for the Carboxyl-Terminal Region of PTH(1-84) Are Highly Expressed in Osteocytic Cells Endocrinology, February 1, 2001; 142(2): 916 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takami, N. Takahashi, N. Udagawa, C. Miyaura, K. Suda, J.-T. Woo, T. J. Martin, K. Nagai, and T. Suda Intracellular Calcium and Protein Kinase C Mediate Expression of Receptor Activator of Nuclear Factor-{{kappa}}B Ligand and Osteoprotegerin in Osteoblasts Endocrinology, December 1, 2000; 141(12): 4711 - 4719. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. O'Brien, I. Gubrij, S.-C. Lin, R. L. Saylors, and S. C. Manolagas STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-kappa B Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone J. Biol. Chem., July 2, 1999; 274(27): 19301 - 19308. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families Endocr. Rev., June 1, 1999; 20(3): 345 - 357. [Abstract] [Full Text] |
||||
![]() |
K. Matsuzaki, K. Katayama, Y. Takahashi, I. Nakamura, N. Udagawa, T. Tsurukai, R. Nishinakamura, Y. Toyama, Y. Yabe, M. Hori, et al. Human Osteoclast-Like Cells Are Formed from Peripheral Blood Mononuclear Cells in a Coculture with SaOS-2 Cells Transfected with the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Gene Endocrinology, February 1, 1999; 140(2): 925 - 932. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |